Inactivation of fusidic acid by pathogenic Nocardia

Journal of Antibiotics

Volumn 52, Issue 3, 1999, Pages 335-339

  Harada, Ken ichi ^a   Tomita, Koji ^a   Fujii, Kiyonaga ^a   Sato, Noriko ^a   Uchida, Hideaki ^a   Yazawa, Katsukiyo ^b   Mikami, Yuzuru ^b  

^a MEIJO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; FUSIDIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOTRANSFORMATION; DRUG INACTIVATION; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0032935271     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.335     Document Type: Article

References (17)

1. MIYADOH, S.; S. AMANO & S. TAKASHI: Strain SF2457, a new producer of amicetin group antibiotics. Actinomycetologica 4: 85-88, 1990
2. TSUDA, M.; H. SATO, Y. TANAKA, K. YAZAWA, Y. MIKAMI, T. SASAKI & J. KOBAYASHI: Brasiliquinones A∼C, new cytotoxic benz[a]anthraquinones with an ethyl group at C-3 from actinomycete Nocardia brasiliensis. J. Chem. Soc., Perkin Trans. 1: 1773-1775, 1996
3. KOBAYASHI, J.; M. TSUDA, A. NEMOTO, Y. TANAKA, K. YAZAWA & Y. MIKAMI: Brasilidine A, a new cytotoxic isonitrile-containing indole alkaloid from the actinomycete Nocardia brasiliensis. J. Nat. Products 60: 719-720, 1997
4. TANAKA, Y.; U. GRAEFE, K. YAZAWA, Y. MIKAMI & M. RITZAU: Nocardicyclins A and B: new anthracycline antibiotics produced by Nocardia pseudobrasiliensis. J. Antibiotics 50: 822-827, 1997
5. SHIGEMORI, H.; Y. TANAKA, K. YAZAWA, Y. MIKAMI & J. KOBAYASHI: Brasilinolide A, new immunosuppressive macrolide from actionomycete, Nocardia brasiliensis. Tetrahedron 52: 9031-9034, 1996
6. SHIGEMORI, H.; H. KOMAKI, K. YAZAWA, Y. MIKAMI, A. NEMOTO, Y. TANAKA, T. SASAKI, Y. IN, T. ISHIDA & J. KOBAYASHI: Brasilicandin A, a novel tricyclic metabolite with potent immunosupperssive activity from actinomycete Nocardia brasiliensis. J. Org. Chem 63: 6900-6904, 1998
7. MIKAMI, Y. & K. YAZAWA: Susceptibility patterns of pathogenic Nocardia to some selected antimicrobial agents and their usefulness in the identification works in a clinical laboratory. Bulletin of the Japan Federation for Culture Collections 5: 89-95, 1989
8. YAZAWA, K.; Y. MIKAMI, A. MAEDA, M. AKAO, N. MORISAKI & S. IWASAKI: Inactivation of rifampin by Nocardia brasiliensis. Antimicrob. Agents Chemother. 37: 1313-1317, 1993
9. YAZAWA, K.; Y. MIKAMI, A. MAEDA, N. MORISAKI & S. IWASAKI: Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J. Antimicrob. Chemother. 33: 1127-1135, 1994
10. YAZAWA, K.; Y. MIKAMI, A. MAEDA, T. SAKAMOTO, Y. UENO, N. MORISAKI, S. IWASAKI & K. FURIHATA: Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species. Antimicrob. Agents Chemother. 38: 2197-2199, 1994
11. MORISAKI, N.; S. IWASAKI, K. FURIHATA, K. YAZAWA & Y. MIKAMI: Structural elucidation of rokitamycin, midecamycin and erythromycin metabolites formed by pathogenic Nocardia. Mag. Res. Chem. 33: 481-489, 1995
12. VON DAEHNE, W.; S. JAHSEN, I. KIRK, R. LARSEN & H. LORCK: Fusidic acid: properties, biosynthesis, and fermentation. Drugs Pharm. Sci. 22: 427-449, 1984
13. VON dER HAAR, B.; D. ROSENBERG, W. DITTRICH & H. SCHREMPF: Inactivation of fusidic acid by resistant Streptomyces strains. J. Antibiotics 44: 785-792, 1991
14. GODTFRESEN, W. O.; W. VON DAEHNE, L. TYBRING & S. VANGEDAL: Fusidic acid derivatives. I. Relationship between structure and antibacterial activity. J. Med. Chem. 9: 15-22, 1966
15. DVONCH, W.; G. GREENSPAN & H. E. ALBURN: Microbiological oxidation of fusidic acid. Experientia 22: 517, 1966
16. VON DAEHNE, W.; H. LORCH & W. O. GODTFREDSEN: Microbiological transformations of fusidane-type antibiotics. A correlation between fusidic acid and helvolic acid. Tetrahedron Lett. 4843-4846, 1968
17. VON DER HAAR, B. & H. SCHREMPF: Purification and characterization of a novel extracellular Streptomyces lividans 66 enzyme inactivating fusidic acid. J. Bacteriol. 177: 152-155, 1995